Kings Point Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $313K | Hold |
4,280
| – | – | 0.03% | 165 |
|
|
2021
Q4 | $267K | Hold |
4,280
| – | – | 0.02% | 201 |
|
|
2021
Q3 | $253K | Buy |
4,280
+200
| +5% | +$13.2K | 0.02% | 187 |
|
|
2021
Q2 | $273K | Hold |
4,080
| – | – | 0.02% | 186 |
|
|
2021
Q1 | $258K | Sell |
4,080
-98
| -2% | -$6.1K | 0.03% | 177 |
|
|
2020
Q4 | $259K | Hold |
4,178
| – | – | 0.03% | 165 |
|
|
2020
Q3 | $252K | Buy |
4,178
+308
| +8% | +$18.5K | 0.03% | 153 |
|
|
2020
Q2 | $228K | Sell |
3,870
-400
| -9% | -$23.9K | 0.03% | 153 |
|
|
2020
Q1 | $238K | Sell |
4,270
-1,263
| -23% | -$77.2K | 0.04% | 147 |
|
|
2019
Q4 | $355K | Sell |
5,533
-430
| -7% | -$24.6K | 0.05% | 141 |
|
|
2019
Q3 | $302K | Buy |
5,963
+1,358
| +29% | +$63.8K | 0.05% | 146 |
|
|
2019
Q2 | $209K | Buy |
4,605
+1,636
| +55% | +$76.2K | 0.04% | 142 |
|
|
2019
Q1 | $142K | Hold |
2,969
| – | – | 0.03% | 148 |
|
|
2018
Q4 | $154K | Hold |
2,969
| – | – | 0.03% | 137 |
|
|
2018
Q3 | $184K | Hold |
2,969
| – | – | 0.03% | 149 |
|
|
2018
Q2 | $164K | Hold |
2,969
| – | – | 0.03% | 156 |
|
|
2018
Q1 | $188K | Hold |
2,969
| – | – | 0.04% | 147 |
|
|
2017
Q4 | $182K | Sell |
2,969
-206
| -6% | -$12.9K | 0.04% | 152 |
|
|
2017
Q3 | $202K | Buy |
3,175
+450
| +17% | +$26.3K | 0.05% | 141 |
|
|
2017
Q2 | $152K | Hold |
2,725
| – | – | 0.04% | 155 |
|
|
2017
Q1 | $148K | Sell |
2,725
-67,533
| -96% | -$3.7M | 0.03% | 151 |
|
|
2016
Q4 | $4.11M | Buy |
70,258
+63,683
| +969% | +$3.48M | 1.01% | 36 |
|
|
2016
Q3 | $355K | Hold |
6,575
| – | – | 0.09% | 94 |
|
|
2016
Q2 | $484K | Hold |
6,575
| – | – | 0.12% | 85 |
|
|
2016
Q1 | $420K | Sell |
6,575
-123
| -2% | -$7.76K | 0.11% | 86 |
|
|
2015
Q4 | $461K | Sell |
6,698
-27
| -0.4% | -$1.78K | 0.11% | 88 |
|
|
2015
Q3 | $398K | Buy |
6,725
+1,700
| +34% | +$108K | 0.1% | 97 |
|
|
2015
Q2 | $334K | Hold |
5,025
| – | – | 0.08% | 107 |
|
|
2015
Q1 | $324K | Sell |
5,025
-506
| -9% | -$31.7K | 0.08% | 107 |
|
|
2014
Q4 | $326K | Buy |
5,531
+506
| +10% | +$28.5K | 0.09% | 95 |
|
|
2014
Q3 | $257K | Hold |
5,025
| – | – | 0.08% | 99 |
|
|
2014
Q2 | $244K | Hold |
5,025
| – | – | 0.07% | 99 |
|
|
2014
Q1 | $261K | Buy |
5,025
+325
| +7% | +$17.3K | 0.09% | 92 |
|
|
2013
Q4 | $250K | Hold |
4,700
| – | – | 0.09% | 88 |
|
|
2013
Q3 | $218K | Buy |
4,700
+500
| +12% | +$21.9K | 0.08% | 91 |
|
|
2013
Q2 | $188K | Buy |
+4,200
| New | +$182K | 0.08% | 104 |
|
Other funds holding BMY
Kings Point Capital Management's BMY Position: Q1 2022 in Review
Kings Point Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2022 at 4,280 shares worth $313K. The position accounts for 0.03% of the portfolio, ranked #165.
Kings Point Capital Management first reported a position in BMY in Q2 2013 and has held it in 36 quarters since. The position peaked at $4.11M in Q4 2016. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.
- Kings Point Capital Management held 4,280 shares of Bristol-Myers Squibb worth $313K as of Q1 2022.
- Kings Point Capital Management left its Bristol-Myers Squibb share count unchanged in Q1 2022.
- Bristol-Myers Squibb made up 0.03% of Kings Point Capital Management's portfolio in Q1 2022, its #165 holding.
- Kings Point Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 36 quarters since.
- Kings Point Capital Management's Bristol-Myers Squibb position peaked at $4.11M in Q4 2016.
- 2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.
Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.